Genentech failed to persuade a single member of the Food and Drug Administration's panel of cancer experts that its blockbuster drug Avastin should keep the agency's seal of approval for treating advanced *** cancer.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/06/29/137508609/expert-panel-tells-fda-to-pull-approval-of-avastin-for-breast-cancer?ft=1&f=103537970
Posted
Jun 29 2011, 02:43 PM
by
NPR Blogs: Shots - Health Blog